UM e Sinopharm estabelecem colaboração em ciências biomédicas

A delegation led by Liu Jingzhen, chairman of China National Pharmaceutical Group Co Ltd (Sinopharm), visited the University of Macau (UM) and was warmly received by UM Rector Yonghua Song and Vice Rector Xu Jian. During the visit, the two parties signed a strategic cooperation agreement to establish collaboration in biomedical sciences.

Song introduced to the delegation UM’s strengths and future development plans. He said that UM attaches great importance to the development of education and research in the field of health sciences and continuously enhances its academic offerings to support national development strategies and step up its support for the development of the biomedical and healthcare industry.

In addition, UM and Sinopharm signed a strategic cooperation agreement, which marks the establishment of a strategic partnership between the two parties based on the principles of complementarity, mutual benefit, pragmatism, and common development. Both parties will engage in in-depth cooperation in various aspects, including establishing joint laboratories, conducting joint translational research, and enhancing the cultivation of technology talent.

The Sinopharm delegation visited the State Key Laboratory of Quality Research in Chinese Medicine and the laboratories of the Faculty of Health Sciences, followed by a meeting. During the meeting, representatives from both sides gave an overview of their respective situations and advantages in cooperation and discussed in depth the details of future cooperation. Both parties hope that their cooperation will play a leading role in integration and mutual promotion, thereby boosting the strategic technological capabilities of Macao and Hengqin in the field of biomedical sciences and healthcare.

Sinopharm is a state-owned enterprise directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It is mainly engaged in the life and health sector and serves the Healthy China strategy. The group holds a leading position globally in terms of scale, profitability, and comprehensive strength within the industry.

Members of the Sinopharm delegation also included Hu Jianwei, party committee member and deputy general manager (daily operations) of Sinopharm; Dong Zenghe, party committee member and deputy general manager of Sinopharm; Jin Bin, deputy general manager of Sinopharm; Zhang Yuntao, chief scientist of Sinopharm and vice president of China National Biotec Group Co Ltd; Zhou Song, party committee secretary and chairman of China Sinopharm International Corporation; Chen Yinglong, party committee secretary and chairman of China Traditional Chinese Medicine Holdings Co Ltd; Ni Feng, vice president of Shanghai Shyndec Pharmaceutical Co Ltd; Yu Min, party committee secretary and chairman of Chongqing Taiji Industry Group Co Ltd; and Lan Qingshan, vice president of China Traditional Chinese Medicine Holdings Co Ltd.